{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:09:36Z","timestamp":1794283776490,"version":"4.9.0"},"reference-count":37,"publisher":"BMJ","issue":"8","funder":[{"DOI":"10.13039\/100007623","name":"Emory University School of Medicine","doi-asserted-by":"crossref","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,1,9]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Limited data are available on the global rates of paediatric multiple sclerosis. Here, we report on the estimated worldwide prevalence of paediatric MS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included paediatric prevalence data in 2020\u20132022 (Multiple Sclerosis International Federation Atlas of MS) and the prevalence of child neurologists (International Child Neurology Association). Data were split into prevalence bands per 100\u2009000. Countries were classified by the WHO Region and World Bank Income. Descriptive analyses were performed. An estimated worldwide prevalence rate was calculated from the 2020\u20132022 paediatric prevalence data, which was adjusted to reduce outliers\u2019 impact and to reflect worldwide income distribution. The Atlas of MS data was obtained via survey of coordinators from the countries who use different tracking methods including national registries vs crude estimates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Paediatric data were available in 24% (53\/219) countries (38 higher and 15 lower income) with 31\u2009420 total paediatric MS cases. In 2022, 67% (10\/15) of lower income countries reported prevalence bands of \u2018&lt;1.0\u2019 compared with 34% (13\/38) of higher income countries. Only 7% (1\/15) of lower income countries reported prevalence bands \u2018\u22653.1\u2019compared with 34% (13\/38) of higher income countries. The rates of child neurologists positively correlated with the prevalence band. In 2020\u20132022, the estimated global prevalence (crude) was 2.53\/100 000 (95% CI 2.51 to 2.56), with an adjusted prevalence rate of 1.48\/100 000 (95% CI 1.45 to 1.51).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Access to epidemiology data from resource-limited countries is challenging including surveillance for case ascertainment. Increased resources and standard methodologies will facilitate the understanding of rare disease epidemiology.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jnnp-2024-335175","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T13:20:31Z","timestamp":1737638431000},"page":"814-820","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Worldwide epidemiology of paediatric multiple sclerosis: data from the Multiple Sclerosis International Federation Atlas of MS, third edition"],"prefix":"10.1136","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-7792","authenticated-orcid":false,"given":"Grace","family":"Gombolay","sequence":"first","affiliation":[{"name":"Emory University, Atlanta, Georgia, USA"},{"name":"Pediatric Neurology, Children's Healthcare of Atlanta, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Johnson","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"King","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis International Federation, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Hebert","sequence":"additional","affiliation":[{"name":"Emory University, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Banwell","sequence":"additional","affiliation":[{"name":"Pediatrics, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Chitnis","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-2347","authenticated-orcid":false,"given":"Anne","family":"Helme","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis International Federation, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025071606150568000_96.8.814.1","doi-asserted-by":"publisher","DOI":"10.1177\/135245852097084"},{"key":"2025071606150568000_96.8.814.2","first-page":"e624","article-title":"Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition","volume":"101","author":"Solomon","year":"2023","journal-title":"Neurology (ECronicon)"},{"key":"2025071606150568000_96.8.814.3","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2020.0069"},{"key":"2025071606150568000_96.8.814.4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331991"},{"key":"2025071606150568000_96.8.814.5","doi-asserted-by":"publisher","DOI":"10.1177\/08830738231176588"},{"key":"2025071606150568000_96.8.814.6","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517713669"},{"key":"2025071606150568000_96.8.814.7","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15015"},{"key":"2025071606150568000_96.8.814.8","first-page":"109","article-title":"Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study","volume":"17","author":"Nasiri","year":"2023","journal-title":"Iran J Child Neurol"},{"key":"2025071606150568000_96.8.814.9","first-page":"234","article-title":"Multiple sclerosis in Israeli children: incidence, an clinical, cerebrospinal fluid and magnetic resonance imaging findings","volume":"14","author":"Achiron","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"2025071606150568000_96.8.814.10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003318"},{"key":"2025071606150568000_96.8.814.11","doi-asserted-by":"publisher","DOI":"10.1177\/0883073820959543"},{"key":"2025071606150568000_96.8.814.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.04.025"},{"key":"2025071606150568000_96.8.814.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2015.06.010"},{"key":"2025071606150568000_96.8.814.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103344"},{"key":"2025071606150568000_96.8.814.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.09.017"},{"key":"2025071606150568000_96.8.814.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09647-9"},{"key":"2025071606150568000_96.8.814.17","doi-asserted-by":"publisher","DOI":"10.1177\/0883073818759103"},{"key":"2025071606150568000_96.8.814.18","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.15098"},{"key":"2025071606150568000_96.8.814.19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002469"},{"key":"2025071606150568000_96.8.814.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2008.04.009"},{"key":"2025071606150568000_96.8.814.21","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.4455"},{"key":"2025071606150568000_96.8.814.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2013.06.004"},{"key":"2025071606150568000_96.8.814.23","first-page":"e2764","article-title":"Long-term disability progression of pediatric-onset multiple sclerosis","volume":"92","author":"McKay","year":"2019","journal-title":"Neurology (ECronicon)"},{"key":"2025071606150568000_96.8.814.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103071"},{"key":"2025071606150568000_96.8.814.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102260"},{"key":"2025071606150568000_96.8.814.26","first-page":"e1813","article-title":"Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level","volume":"99","author":"Hwang","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2025071606150568000_96.8.814.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207633"},{"key":"2025071606150568000_96.8.814.28","unstructured":"MSIF . Data from: Atlas of MS, 2023. Available: https:\/\/www.atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms"},{"key":"2025071606150568000_96.8.814.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-004-6517-4"},{"key":"2025071606150568000_96.8.814.30","unstructured":"World Health Organization Regions, 2023. Available: https:\/\/www.atlasofms.org\/map\/global\/country-classification\/who-region"},{"key":"2025071606150568000_96.8.814.31","unstructured":"World Bank Income Bands, Available: https:\/\/www.atlasofms.org\/map\/global\/country-classification\/world-bank-income-band"},{"key":"2025071606150568000_96.8.814.32","unstructured":"MS Ao . Number of People with MS, 2023. Available: https:\/\/www.atlasofms.org\/map\/global\/epidemiology\/number-of-people-with-ms"},{"key":"2025071606150568000_96.8.814.33","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22366"},{"key":"2025071606150568000_96.8.814.34","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2025071606150568000_96.8.814.35","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(22)00431-8"},{"key":"2025071606150568000_96.8.814.36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S2352-4642(24)00047-6","article-title":"Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries","volume":"8","author":"Sharmin","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"2025071606150568000_96.8.814.37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/13524585231205970","article-title":"Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation","volume":"30","author":"Yamout","year":"2024","journal-title":"Mult Scler"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2024-335175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:15:21Z","timestamp":1752671721000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2024-335175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,7,16]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/jnnp-2024-335175"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2024-335175","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]}}}